MedCity News
Oncobiologics: The most interesting biotech at #JPM17?

By JULIET PRESTON
Jan. 10, 2017

Innovation. It’s why thousands of biotech, pharma and healthcare professionals are currently dashing around Union Square. It’s exciting and awe-inspiring and it captures the media’s attention.

At the other end of the spectrum is Oncobiologics, a company fully dedicated to producing biosimilars.

There’s no new pathway or technique involved in any of its work. Its mission is to replicate existing biologics. That means that everything depends on the efficiency and effectiveness of the business model. 

What can it deliver?

Please click on the link to read the rest of the story …
Oncobiologics: The most interesting biotech at #JPM17?

< back